Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 465 entries
View as:

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)

Phase: N/A Priority: Normal
NCT ID: NCT00964990 Org: User:
Start: 09/30/09 End: 07/31/11 Due: 07/31/12

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01202734 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00992589 Org: User:
Start: 11/30/09 End: 11/30/11 Due: 11/30/12

A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT00210613 Org: User:
Start: 11/30/04 End: 08/31/05 Due: 08/31/06

An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

Phase: N/A Priority: Normal
NCT ID: NCT00796120 Org: User:
Start: 11/30/08 End: 08/31/14 Due: 08/31/15

A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00892320 Org: User:
Start: 03/31/04 End: 05/31/04 Due: 05/31/05

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00412373 Org: User:
Start: 12/31/06 End: 06/30/08 Due: 06/30/09

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

Phase: N/A Priority: Normal
NCT ID: NCT00210587 Org: User:
Start: 02/28/05 End: 12/31/05 Due: 12/31/06

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT00097032 Org: User:
Start: 10/31/04 End: 05/31/05 Due: 05/31/06

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00240695 Org: User:
Start: 05/31/03 End: 05/31/04 Due: 05/31/05

A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00212875 Org: User:
Start: 09/30/05 End: 02/28/07 Due: 02/28/08

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00440466 Org: User:
Start: 07/31/07 End: 03/31/09 Due: 03/31/10

A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00097981 Org: User:
Start: 01/31/05 End: 10/31/09 Due: 10/31/10

A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00791284 Org: User:
Start: 08/31/04 End: 12/31/04 Due: 12/31/05

Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00331071 Org: User:
Start: 04/30/02 End: 03/31/06 Due: 03/31/07

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00515034 Org: User:
Start: 10/31/07 End: 11/30/08 Due: 11/30/09

A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00672386 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01986491 Org: User:
Start: 05/31/09 End: 08/31/09 Due: 08/31/10

A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately

Phase: N/A Priority: Normal
NCT ID: NCT00752466 Org: User:
Start: 03/31/03 End: 03/31/04 Due: 03/31/05

A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00269984 Org: User:
Start: - End: 06/30/90 Due: 06/30/91

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00253188 Org: User:
Start: 02/28/97 End: 12/31/98 Due: 12/31/99

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00236431 Org: User:
Start: 05/31/01 End: 12/31/03 Due: 12/31/04

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00334126 Org: User:
Start: 04/30/06 End: 09/30/07 Due: 09/30/08

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00304629 Org: User:
Start: 03/31/00 End: 03/31/02 Due: 03/31/03

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00236743 Org: User:
Start: 06/30/94 End: 10/31/00 Due: 10/31/01